Navigation Links
FHI Selected as Preferred Provider to a Consortium of Product Development Partnerships
Date:3/30/2011

RESEARCH TRIANGLE PARK, N.C., March 30, 2011 /PRNewswire-USNewswire/ -- FHI has been selected as one of six preferred providers offering their clinical research expertise to a consortium of 14 global health Product Development Partnerships (PDPs). The consortium of PDPs is working to develop and deliver affordable treatments and vaccines that will help improve the lives of some of the world's most vulnerable people.

FHI's forty years of research experience has focused on a multitude of infectious and neglected diseases, such as HIV, HSV, HPV, other sexually transmitted diseases, malaria, and seasonal and pandemic influenza.  FHI has strong history delivering the highest quality research in resource constrained settings and has been recognized globally for its leadership in the ethical treatment of trial participants.  

"This consortium has the potential to find cures for the most widespread diseases, like tuberculosis, malaria, influenza, dengue fever, HIV and Chagas disease," said Albert J. Siemens, FHI Chairman and Chief Executive Officer.  "FHI is honored to be selected as a preferred provider, offering our expertise and experience to the critical work being undertaken by the PDPs."

The consortium members are funded, in part, by the Bill & Melinda Gates Foundation. This preferred provider agreement offers consortium members an opportunity to work with pre-qualified organizations, including FHI, thereby consolidating resources, and achieving heightened efficiencies while maintaining the highest standards.  The synergies and efficiencies of partnering with the preferred providers are expected to be significant.  

FHI partners with government, non-governmental, and private sector entities on major pharmaceutical and biotechnology clinical trials worldwide.

About FHI

FHI is a global health and development organization whose science-based programs bring lasting change to the world's most vulnerable people.  FHI's approach is rigorous and evidence-driven.  Among FHI's worldwide staff of 2,500 are leading physicians, scientists, and technical experts in health, development, and management.  FHI's work is global in scale yet country-focused, with international offices staffed by local professionals.  Since 1971, FHI has worked with 1,400 partners in 125 countries, forging strong relationships with governments, diverse organizations, the private sector and communities.  By applying science to healthcare programs and clinical research, FHI is helping countries make measurable progress against disease, poverty, and inequity – improving lives for millions.

Contact Info:
Matthew Matassa
202-341-6519
mmatassa@fhi.org


'/>"/>
SOURCE Family Health International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics Selected for Inclusion in RB Milestone Portfolio
2. Shanghai ChemPartner Announces Being Selected as Antibody Service Partner by Shenogen Pharma Group
3. NewCardio Study of QTinno Accuracy Selected for Presentation at the National Scientific Meeting of the American Society of Clinical Pharmacology and Therapeutics
4. BioSurplus Selected to Liquidate Discovery Laboratory Equipment
5. Cognizant Selected by Lilly to Deliver Commercial Operations Solutions to Enhance Sales and Marketing Effectiveness, Business Performance
6. Valence Health Selected by Cleveland Clinic to Support Clinical Integration Program
7. Compumedics Home Sleep Testing System Selected for Use in US National Institute of Health (NIH)-Sponsored Multi-Ethnic Study of Atherosclerosis (MESA) Sleep Study
8. Cylene Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hematology Meeting
9. GENFIT Selected by Windhover for the 2011 Top Biopharma Projects To Watch
10. PolyOne GLS Selected as Healthcare Industry Marketing Specialist for Santoprene™ TPV Medical Grades
11. Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... YORK , March 24, 2017 ... and Equipment stocks, which are: Neovasc Inc. (NASDAQ: NVCN), Hologic ... Heart Inc. (NASDAQ: SSH ). These companies are ... its prior gains on Thursday, March 23 rd , 2017, ... afternoon, while shares of health care companies in the S&P ...
(Date:3/24/2017)...  Mirabilis Medical, a Seattle ... surgery, announced today CE Mark authorization for marketing ... fibroids throughout the European Union.  The company simultaneously ... US Food and Drug Administration to begin a ... United States.  The Mirabilis System combines high-speed therapeutic ...
(Date:3/23/2017)... MOBILE, Ala. , March 23, 2017 Mosaic Life Care, based in ... automate the patient registration process across its network of 58 clinics, located in 22 ... constantly seeking new and innovative ways to improve the delivery of health care to ... Continue Reading ... Mosaic Life Care St. Joseph ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... ... “Vintage and Harvest A Cultivation of Christian Love” is the creation of ... Carolina with his wife, Anna Marie. He and his wife are the proud parents ... the author of “Shadow and Substance.” , “Love, the agape kind, is seen as ...
(Date:3/24/2017)... ... , ... “The Adventures of Joey, The Dog Who Barks at Puddles”: a ... to the fullest, as God intended. “The Adventures of Joey, The Dog Who Barks ... pursuing her passion for writing, especially about truth and human behavior. , Published by ...
(Date:3/23/2017)... ... March 23, 2017 , ... A recent report from ... into teacher preparation programs. The NCTQ report suggests, based on a review of GPA ... significantly improve teacher quality in the U.S. It argues that this higher bar should ...
(Date:3/23/2017)... ... 2017 , ... Demonstrating their commitment to improving health and ... have been awarded national accreditation through the Public Health Accreditation Board ... of communities across the nation whose health departments meet rigorous national standards for ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... City Convention Center at 10 North Broadway Avenue, will be an educational and ... relevant, practical instruction in the management of chronic pain. , Oklahoma is in ...
Breaking Medicine News(10 mins):